SCHEMBL4453216

SCHEMBL4453216

Cc1ccccc1N(c1ccccc1)c1ccc(N(c2ccccc2)c2ccccc2)c(N(c2ccccc2)c2ccccc2C)c1N(c1ccccc1)c1ccccc1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.33
LMNA P02545 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
TSHR P16473 1/20 0.33
ACHE P22303 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.33
OPRM1 P35372 2/20 0.32
APP P05067 1/20 0.31
SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3513273 0.88 TSHR (0.39) CYP3A4LMNAKDM4EALDH1A1CYP1A2
SCHEMBL8470149 0.88 TSHR (0.43) CYP3A4LMNAKDM4EALDH1A1CYP1A2
SCHEMBL186536 0.88 TSHR (0.43) CYP3A4LMNAKDM4EALDH1A1CYP1A2
SCHEMBL15247033 0.86 ALDH1A1 (0.46) CYP3A4LMNAKDM4EALDH1A1CYP1A2
Phosphine SCHEMBL28302574 0.86 TSHR (0.41) CYP3A4LMNAKDM4EALDH1A1CYP1A2
SCHEMBL8943827 0.86 ALDH1A1 (0.44) CYP3A4LMNAKDM4EALDH1A1CYP1A2
SCHEMBL7149189 0.86 TSHR (0.41) CYP3A4LMNAKDM4EALDH1A1CYP1A2
SCHEMBL13826304 0.84 TSHR (0.36) CYP3A4LMNAKDM4EALDH1A1CYP1A2
SCHEMBL25977677 0.84 HDAC6 (0.32) CYP3A4LMNAKDM4EALDH1A1CYP1A2
SCHEMBL3477596 0.84 ALDH1A1 (0.48) CYP3A4LMNAKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240407244-A1 MIXED POWDER FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND METHOD FOR PRODUCING THE SAME, METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE BY USING THE MIXED POWDER, METHOD FOR SELECTING COMPOUNDS IN THE MIXED POWDER, AND COMPOSITION FOR VACUUM DEPOSITION IDEMITSU KOSAN CO.,LTD. (JP) 2024-12-05 US disclosed
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-10-03 US disclosed
CN-118339941-A Mixed powder and method for producing same, method for producing organic electroluminescent element using same, method for selecting compound in mixed powder, and composition for vacuum vapor deposition 出光兴产株式会社 2024-07-12 CN disclosed
CN-117616909-A Mixed powder for organic electroluminescent element and method for producing same, method for producing organic electroluminescent element using same, method for selecting compound in mixed powder, and composition for vacuum evaporation 出光兴产株式会社 2024-02-27 CN disclosed
CN-117581654-A Mixed powder, mixed body, and method for manufacturing organic electroluminescent element 出光兴产株式会社 2024-02-20 CN disclosed
EP-4169080-A1 MULTIJUNCTION PHOTOVOLTAIC DEVICES WITH METAL OXYNITRIDE LAYER Oxford Photovoltaics Limited (GB) 2023-04-26 EP disclosed
US-20230001447-A1 MIXED POWDER, METHOD OF VAPOR-DEPOSITING ORGANIC COMPOUND, METHOD OF FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE, METHOD OF SELECTING ORGANIC COMPOUNDS, AND METHOD OF VAPOR-DEPOSITING IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-05 US disclosed
US-11411182-B1 Mixed powder for organic electroluminescence device and method of producing the same, method of fabricating organic electroluminescence device using the mixed powder, method of selecting compounds for the mixed powder, and composition for vacuum vapor deposition IDEMITSU KOSAN CO., LTD. (JP) 2022-08-09 US disclosed
EP-3997740-A1 MULTI-JUNCTION PHOTOVOLTAIC DEVICE Oxford Photovoltaics Limited (GB) 2022-05-18 EP disclosed
EP-3970209-A1 PHOTOVOLTAIC DEVICE Oxford Photovoltaics Limited (GB) 2022-03-23 EP disclosed
EP-3489240-A1 IN-SITU CROSS-LINKABLE HOLE TRANSPORTING TRIAZATRUXENE MONOMERS FOR OPTOELECTRONIC DEVICESTR Ecole Polytechnique Fédérale de Lausanne (EPFL) (CH) 2019-05-29 EP disclosed
EP-3345230-A1 DOUBLE PEROVSKITE Oxford University Innovation Limited (GB) 2018-07-11 EP disclosed
EP-3308401-A1 MULTIJUNCTION PHOTOVOLTAIC DEVICE Oxford Photovoltaics Limited (GB) 2018-04-18 EP disclosed
EP-1753047-B1 Solution processed crosslinkable hole injection and hole transport polymers for oleds OSRAM OLED GMBH (DE) 2017-04-12 EP disclosed
WO-2017037448-A1 DOUBLE PEROVSKITE OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2017-03-09 WO disclosed
EP-2898553-A1 OPTOELECTRONIC DEVICE Isis Innovation Limited (GB) 2015-07-29 EP disclosed
WO-2014045021-A1 OPTOELECTRONIC DEVICE ISIS INNOVATION LIMITED (GB) 2014-03-27 WO disclosed
US-7576356-B2 Solution processed crosslinkable hole injection and hole transport polymers for OLEDs OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2009-08-18 US disclosed
EP-1753047-A2 Solution processed crosslinkable hole injection and hole transport polymers for oleds Osram Opto Semiconductors GmbH (DE) 2007-02-14 EP disclosed
US-20070029556-A1 Solution processed crosslinkable hole injection and hole transport polymers for OLEDs OSRAM OPTO SEMICONDUCTORS GMBH 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE EML4, ORC3, ZRANB2 CYP3A4 1079/4885LMNA 1743/4885KDM4E 1805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.